Globus Medical Inc. Class A

58.29+0.5500+0.95%Vol 727.36K1Y Perf -28.67%
Sep 23rd, 2022 16:00 DELAYED
BID56.52 ASK60.17
Open57.02 Previous Close57.74
Pre-Market- After-Market58.29
 - -  - -%
Target Price
79.54 
Analyst Rating
Moderate Buy 1.78
Potential %
36.46 
Finscreener Ranking
★★     44.28
Insiders Trans % 3/6/12 mo.
-/-100/-100 
Value Ranking
★★+     48.94
Insiders Value % 3/6/12 mo.
-/-100/-100 
Growth Ranking
★★★★+     62.89
Insiders Shares Cnt. % 3/6/12 mo.
-/-100/-100 
Income Ranking
 —    -
Price Range Ratio 52W %
19.50 
Earnings Rating
Neutral
Market Cap5.80B 
Earnings Date
3rd Nov 2022
Alpha0.00 Standard Deviation0.09
Beta1.15 

Today's Price Range

56.2158.33

52W Range

52.6081.78

5 Year PE Ratio Range

21.8084.20

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
-4.38%
1 Month
-5.45%
3 Months
0.76%
6 Months
-15.84%
1 Year
-28.67%
3 Years
13.80%
5 Years
99.08%
10 Years
252.85%

TickerPriceChg.Chg.%
GMED58.290.55000.95
AAPL150.43-2.3100-1.51
GOOG99.17-1.4000-1.39
MSFT237.92-3.0600-1.27
XOM85.75-4.8200-5.32
WFC40.41-1.1100-2.67
JNJ166.720.54000.32
FB196.640.99000.51
GE64.55-0.8100-1.24
JPM109.14-2.0700-1.86
 
ProfitabilityValueIndustryS&P 500US Markets
74.50
20.10
27.00
20.20
16.04
RevenueValueIndustryS&P 500US Markets
973.94M
9.79
8.61
9.45
Earnings HistoryEstimateReportedSurprise %
Q02 20220.540.563.70
Q01 20220.460.42-8.70
Q04 20210.480.492.08
Q03 20210.450.5011.11
Q02 20210.450.5624.44
Q01 20210.360.4936.11
Q04 20200.510.5813.73
Q03 20200.310.4958.06
Earnings Per EndEstimateRevision %Trend
6/2022 QR0.541.89Positive
9/2022 QR0.531.92Positive
12/2022 FY2.100.00-
12/2023 FY2.400.00-
Next Report Date3rd Nov 2022
Estimated EPS Next Report0.56
Estimates Count7
EPS Growth Next 5 Years %10.00
Volume Overview
Volume727.36K
Shares Outstanding99.52K
Shares Float78.44M
Trades Count15.40K
Dollar Volume41.73M
Avg. Volume585.17K
Avg. Weekly Volume569.36K
Avg. Monthly Volume595.25K
Avg. Quarterly Volume590.91K

Globus Medical Inc. Class A (NYSE: GMED) stock closed at 58.29 per share at the end of the most recent trading day (a 0.95% change compared to the prior day closing price) with a volume of 727.36K shares and market capitalization of 5.80B. Is a component of Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 2200 people. Globus Medical Inc. Class A CEO is David M. Demski.

The one-year performance of Globus Medical Inc. Class A stock is -28.67%, while year-to-date (YTD) performance is -19.27%. GMED stock has a five-year performance of 99.08%. Its 52-week range is between 52.6 and 81.78, which gives GMED stock a 52-week price range ratio of 19.50%

Globus Medical Inc. Class A currently has a PE ratio of 40.90, a price-to-book (PB) ratio of 3.57, a price-to-sale (PS) ratio of 6.17, a price to cashflow ratio of 26.90, a PEG ratio of 2.32, a ROA of 8.78%, a ROC of 9.29% and a ROE of 9.85%. The company’s profit margin is 16.04%, its EBITDA margin is 27.00%, and its revenue ttm is $973.94 Million , which makes it $9.79 revenue per share.

Of the last four earnings reports from Globus Medical Inc. Class A, there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.56 for the next earnings report. Globus Medical Inc. Class A’s next earnings report date is 03rd Nov 2022.

The consensus rating of Wall Street analysts for Globus Medical Inc. Class A is Moderate Buy (1.78), with a target price of $79.54, which is +36.46% compared to the current price. The earnings rating for Globus Medical Inc. Class A stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Globus Medical Inc. Class A has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Globus Medical Inc. Class A has a Sell technical analysis rating based on Technical Indicators (ADX : 6.68, ATR14 : 2.23, CCI20 : -123.56, Chaikin Money Flow : 0.22, MACD : -0.57, Money Flow Index : 31.67, ROC : -3.54, RSI : 66.37, STOCH (14,3) : 26.87, STOCH RSI : 0.08, UO : 52.55, Williams %R : -73.13), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Globus Medical Inc. Class A in the last 12-months were: David D. Davidar (Sold 31 500 shares of value $2 458 071 ), James R. Tobin (Sold 0 shares of value $-1 051 218 ), James R. Tobin (Sold 23 334 shares of value $1 602 664 ), Kelly G. Huller (Sold 0 shares of value $-38 350 ), Kelly G. Huller (Sold 2 500 shares of value $188 963 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
5 (55.56 %)
5 (55.56 %)
6 (60.00 %)
Moderate Buy
1 (11.11 %)
1 (11.11 %)
1 (10.00 %)
Hold
3 (33.33 %)
3 (33.33 %)
3 (30.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
1.78
Moderate Buy
1.78
Moderate Buy
1.70

Globus Medical Inc. Class A

Globus Medical is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which includes medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which includes advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States.

CEO: David M. Demski

Telephone: +1 610 930-1800

Address: 2560 General Armistead Avenue, Audubon 19403, PA, US

Number of employees: 2 200

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

58%42%

Bearish Bullish

51%49%

Bearish Bullish

65%35%

TipRanks News for GMED

Tue, 09 Aug 2022 04:45 GMT Globus Medical (GMED) Gets a Hold from JMP Securities

- TipRanks. All rights reserved.

Fri, 15 Jul 2022 16:43 GMT Globus Medical (GMED) Gets a Hold Rating from Morgan Stanley

- TipRanks. All rights reserved.

News

Stocktwits